Morphologic and biochemical changes caused by experimentally induced dicroceliosis in hamsters (Mesocricetus auratus).
OBJECTIVE
The aim of the study reported here was to investigate the pathomorphologic changes caused by experimentally induced dicroceliosis and their correlation with hepatobiliary function.


METHODS
Studies were carried out at days 80 and 120 after oral inoculation of hamsters with 40 metacercariae of Dicrocoelium dendriticum.


RESULTS
The parasite-induced pathologic changes were assessed by presence of fluke eggs in feces, increased plasma alanine transaminase and aspartate transaminase activities and morphologic alterations. Dicroceliosis was characterized by bile ductular proliferation and enlargement of the bile duct surface area caused by hyperplastic cholangitis in septal bile ducts. The liver from infected animals contained portal tracts infiltrated with small to moderate numbers of lymphocytes, macrophages, and eosinophils. Simultaneously, there was an increase in portal tract collagen that extended to the interlobular septa and caused pressure atrophy of the hepatic parenchyma. The concentration of thiobarbituric acid-reactive substances and the ratio of oxidized to reduced glutathione, measured as markers of oxidative stress, were significantly increased.


CONCLUSIONS
The presence of oxidative alterations could be related to the morphologic evidence of chronic inflammatory response as well as to liver cellular injury indicated by cellular swelling, and increased presence of peroxisomes and lysosomes.
Sánchez-Campos
S
S
Department of Physiology, University of León, Spain.
González
P
P
Ferreras
C
C
García-Iglesias
M J
MJ
González-Gallego
J
J
Tuñón
M J
MJ
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001652:Bile Ducts / Q000469:parasitology / Q000473:pathology; D006224:Cricetinae; D004011:Dicrocoeliasis / Q000469:parasitology / Q000473:pathology* / Q000503:physiopathology*; D004013:Dicrocoelium / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D004804:Eosinophils / Q000473:pathology; D005978:Glutathione / Q000378:metabolism; D019803:Glutathione Disulfide / Q000378:metabolism; D006099:Granuloma / Q000276:immunology / Q000473:pathology; D008099:Liver / Q000469:parasitology / Q000473:pathology* / Q000503:physiopathology*; D008214:Lymphocytes / Q000473:pathology; D008264:Macrophages / Q000473:pathology; D008297:Male; D008647:Mesocricetus; D010063:Ovum / Q000276:immunology; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism
D017392:Thiobarbituric Acid Reactive Substances; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005978:Glutathione; D019803:Glutathione Disulfide